Botulinum toxin a does not improve the results of cast treatment for idiopathic toe-walking a randomized controlled trial

Journal of Bone and Joint Surgery

Volumn 95, Issue 5, 2013, Pages 400-407

  Engström, Pähr ^a   Bartonek, Asa ^a   Tedroff, Kristina ^a   Orefelt, Christina ^b   Haglund Akerlind, Yvonne ^c   Gutierrez Farewik, Elena M ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Aleris specialistvård Sabbatsberg ^*  (Sweden)

^c Department of Otorhinolaryngology   (Sweden)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADOLESCENT; ANKLE; ARTICLE; CAST APPLICATION; CAST REMOVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GAIT DISORDER; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC TOE WALKING; KNEE FUNCTION; LEG PAIN; MALE; ORTHOPEDIC CAST; OUTCOME ASSESSMENT; PASSIVE MOVEMENT; PHYSIOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; SCHOOL CHILD; SKIN DISEASE; STRENGTH; THREE DIMENSIONAL IMAGING; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFECT; GAIT; INTENTION TO TREAT ANALYSIS; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PLASTER CAST; TOE;

ADOLESCENT; ANKLE JOINT; BOTULINUM TOXINS, TYPE A; CASTS, SURGICAL; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GAIT; HUMANS; INJECTIONS, INTRAMUSCULAR; INTENTION TO TREAT ANALYSIS; MALE; NEUROMUSCULAR AGENTS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; TOES;

MLCS; MLOWN;

EID: 84876423120     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00889     Document Type: Article

References (30)

1. Tachdjian M. The Child's foot. Philadelphia: WB Saunders; 1985.
2. Griffin PP,Wheelhouse WW, Shiavi R, Bass W. Habitual toe-walkers. A clinical and electromyographic gait analysis. J Bone Joint Surg Am. 1977;59(1): 97-101.
3. Brouwer B, Davidson LK, Olney SJ. Serial casting in idiopathic toe-walkers and children with spastic cerebral palsy. J Pediatr Orthop. 2000;20(2): 221-5.
4. Fox A, Deakin S, Pettigrew G, Paton R. Serial casting in the treatment of idiopathic toe-walkers and review of the literature. Acta Orthop Belg. 2006;72(6): 722-30.
5. Hall JE, Salter RB, Bhalla SK. Congenital short tendo calcaneus. J Bone Joint Surg Br. 1967;49(4): 695-7.
6. Kogan M, Smith J. Simplified approach to idiopathic toe-walking. J Pediatr Orthop. 2001;21(6): 790-1.
7. Stricker SJ, Angulo JC. Idiopathic toe walking: a comparison of treatment methods. J Pediatr Orthop. 1998;18(3): 289-93.
8. Hemo Y, Macdessi SJ, Pierce RA, Aiona MD, Sussman MD. Outcome of patients after Achilles tendon lengthening for treatment of idiopathic toe walking. J Pediatr Orthop. 2006;26(3): 336-40.
9. Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993;13(4): 489-95.
10. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol. 1994 May;36(5): 386-96.
11. Brashear A. Botulinum toxin type A: Exploring new indications. Drugs Today (Barc). 2010;46(9): 671-82.
12. Jacks LK, Michels DM, Smith BP, Koman LA, Shilt J. Clinical usefulness of botulinum toxin in the lower extremity. Foot Ankle Clin. 2004;9(2): 339-48.
13. Brunt D,Woo R, KimHD, Ko MS, Senesac C, Li S. Effect of botulinum toxin type A on gait of children who are idiopathic toe-walkers. J Surg Orthop Adv. 2004;13(3): 149-55.
14. Engstrom P, Gutierrez-Farewik EM, Bartonek A, Tedroff K, Orefelt C, Haglund- Akerlind Y. Does botulinum toxin A improve the walking pattern in children with idiopathic toe-walking? J Child Orthop. 2010 Aug;4(4): 301-8. Epub 2010 May 12.
15. EastwoodDM,MenelausMB, Dickens DR, Broughton NS, ColeWG. Idiopathic toewalking: does treatment alter the natural history? J Pediatr Orthop B 2000;9-1: 47-9.
16. Accardo P, Whitman B. Toe walking. A marker for language disorders in the developmentally disabled. Clin Pediatr (Phila). 1989 Aug;28(8): 347-50.
17. Accardo P, Morrow J, Heaney MS, Whitman B, Tomazic T. Toe walking and language development. Clin Pediatr (Phila). 1992;31(3): 158-60.
18. Shulman LH, Sala DA, Chu ML, McCaul PR, Sandler BJ. Developmental implications of idiopathic toe walking. J Pediatr. 1997;130(4): 541-6.
19. Kadesjö B, Janols LO, Korkman M, Mickelsson K, Strand G, Trillingsgaard A, Gillberg C, The FTF. (Five to Fifteen): the development of a parent questionnaire for the assessment of ADHD and comorbid conditions. Eur Child Adolesc Psychiatry. 2004;13(Suppl 3): 3-13.
20. Bohlin G, Janols LO. Behavioural problems and psychiatric symptoms in 5-13 year-old Swedish children-A comparison of parent ratings on the FTF (Five to Fifteen) with the ratings on CBCL (Child Behavior Checklist). Eur Child Adolesc Psychiatry. 2004;13(Suppl 3): 14-22.
21. Trillingsgaard A, Damm D, Sommer S, Jepsen JR, Ostergaard O, Frydenberg M, Thomsen PH. Developmental profiles on the basis of the FTF (Five to Fifteen) questionnaire-clinical validity and utility of the FTF in a child psychiatric sample. Eur Child Adolesc Psychiatry. 2004;13(Suppl 3): 39-63.
22. Davis RB, Onunpuu S, Tyberski D, Gage Jr. A gait analysis data collection and reduction technique. Hum Mov Sci. 1991;10(5): 575-87.
23. Alvarez C, De Vera M, Beauchamp R, Ward V, Black A. Classification of idiopathic toe walking based on gait analysis: development and application of the ITW severity classification. Gait Posture. 2007;26(3): 428-35.
24. Eek MN, Kroksmark AK, Beckung E. Isometric muscle torque in children 5 to 15 years of age: normative data. Arch Phys Med Rehabil. 2006;87(8): 1091-9.
25. Hof AL. Scaling gait data to body size. Letter to editor. Gait Posture. 1996; 4(3): 222-3.
26. Kay RM, Rethlefsen SA, Fern-Buneo A, Wren TA, Skaggs DL. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am. 2004;86-A(11): 2377-84.
27. Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, Sanders J, D'Astous J, Aiona MD; Shriners Hospitals BTX-A Study Group. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol. 2005;47(9): 620-7.
28. Katz MM, Mubarak SJ. Hereditary tendo Achillis contractures. J Pediatr Orthop. 1984;4(6): 711-4.
29. Gossman MR, Sahrmann SA, Rose SJ. Review of length-associated changes in muscle. Experimental evidence and clinical implications. Phys Ther. 1982; 62(12): 1799-808.
30. Gajdosik RL. Passive extensibility of skeletal muscle: review of the literature with clinical implications. Clin Biomech (Bristol, Avon). 2001;16(2): 87-101.